Aptevo Therapeutics Inc.APVONASDAQ
Loading
EBITDA Margin Over TimeStrong
Percentile Rank82
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
0.00%
↑ 100% vs avg
Percentile
P82
Within normal range
Average
-257.36%
Historical baseline
PeriodValueYoY Change
20240.00%-
20230.00%+100.0%
2022-890.82%-440.6%
2021-164.79%+72.9%
2020-607.75%-
20190.00%+100.0%
2018-213.62%+38.4%
2017-346.72%-96.2%
2016-176.75%-2.1%
2015-173.19%-